Home Medicine STAT+: Biospring Partners closes $245 million first fund as private markets tense...

STAT+: Biospring Partners closes $245 million first fund as private markets tense up

42
0



When Michelle Dipp and Jennifer Lum decided to launch a life sciences growth equity fund two years ago, the market looked very different.

The Covid-19 pandemic was driving investors in droves to biotech and pharma companies. Automation and drug manufacturing were becoming hot topics.

Continue to STAT+ to read the full story…

Previous articleFostering A Data Culture Within An Organization
Next articleNava Benefits Nabs $40M to Bring F500 Healthcare Benefits Downstream